CSI Market
Sign In | Register

Vir Biotechnology Inc (VIR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VIR Annual Balance Sheets →
The table below presents a historical view of Vir Biotechnology Inc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent274.16
Restricted Cash and Cash Equivalents, Current1.93
Marketable Securities, Current SH196.28
Cash & Short-term Investments471.00
Other Current Assets5.86
Prepaid Expense And Other Assets Current44.76
Total Current Assets522.99
Equipment/Property/Plant Net53.16
Goodwill net16.94
Intangible Assets7.78
Long-term investments332.97
Other Assets, Noncurrent91.76
Operating Lease Right Of Use Asset60.76
Total Assets1,025.59
Liabilities
Accounts Payable, Current AC5.45
Accrued Liabilities, Current68.11
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.00
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities73.56
Total Long-term Debt0.00
Other liabilities, Noncurrent139.26
Operating Lease Liability Noncurrent86.64
Total Liabilities212.82
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock2,139.70
Retained Earnings / Accumulated Deficit-1,323.47
Other Equity-3.48
Common Stockholder's Equity812.77
Total Stockholder's Equity812.77
Liabilities & Stockholder's Equity1,025.59
4 historic quarters locked

Sign in to unlock the full Vir Biotechnology Inc balance sheet history.

Sign In Create Free Account

About Vir Biotechnology Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 5, 2026
  • Source: vir-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-053549

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.